Stockscreener 앱 받기
11.03
0.90%
-0.10
시간 외 거래:
11.03
전일 마감가:
$11.13
열려 있는:
$11.09
하루 거래량:
172.08K
Relative Volume:
0.64
시가총액:
$551.51M
수익:
$62.02M
순이익/손실:
$-45.65M
주가수익비율:
-11.99
EPS:
-0.92
순현금흐름:
$-9.60M
1주 성능:
-1.96%
1개월 성능:
+4.25%
6개월 성능:
+5.35%
1년 성능:
+8.03%
1일 변동 폭
$10.95
$11.18
1주일 범위
$10.95
$11.41
52주 변동 폭
$7.44
$11.88
Theravance Biopharma Inc Stock (TBPH) Company Profile
명칭
Theravance Biopharma Inc
전화
650-808-6000
주소
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
TBPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TBPH
Theravance Biopharma Inc
|
11.03 | 556.51M | 62.02M | -45.65M | -9.60M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-04-12 | 개시 | BTIG Research | Buy |
| 2024-01-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2021-11-05 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-15 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2021-08-25 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2021-08-24 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-10-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-07 | 개시 | JP Morgan | Overweight |
| 2020-06-15 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-05-13 | 개시 | Cowen | Outperform |
| 2020-01-08 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-06 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
| 2019-10-29 | 개시 | H.C. Wainwright | Buy |
| 2018-03-29 | 재개 | Piper Jaffray | Overweight |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-06-16 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-05-11 | 재확인 | Needham | Buy |
| 2016-12-21 | 개시 | Needham | Buy |
| 2016-11-03 | 개시 | Piper Jaffray | Overweight |
| 2016-10-12 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2016-08-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2016-06-20 | 개시 | Guggenheim | Buy |
| 2016-06-20 | 재확인 | Leerink Partners | Outperform |
| 2016-05-12 | 개시 | Leerink Partners | Outperform |
| 2016-05-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2015-02-03 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
모두보기
Theravance Biopharma Inc 주식(TBPH)의 최신 뉴스
What are the technical indicators suggesting about Theravance Biopharma Inc.Get expert analysis on top stock picks - jammulinksnews.com
How many analysts rate Theravance Biopharma Inc. as a “Buy”Achieve rapid returns with smart investment plans - jammulinksnews.com
What are analysts’ price targets for Theravance Biopharma Inc. in the next 12 monthsTrack high-yield stocks before they peak - jammulinksnews.com
Is Theravance Biopharma Inc. stock overvalued or undervaluedInvest confidently with data-driven strategies - jammulinksnews.com
What are the latest earnings results for Theravance Biopharma Inc.Consistent high-performance stocks - jammulinksnews.com
Moving Average Trends for Theravance Biopharma Inc. Stock: What They IndicateHigh Accuracy Alerts - Newser
Is Theravance Biopharma Inc. stock a good hedge against inflationFree Short-Term Stock Picks - Newser
Theravance Biopharma Inc. Stock Performance After Earnings: Historical InsightsFree VIP Investment Strategies - Newser
What makes Theravance Biopharma Inc. stock price move sharplyMinimized Risk Trading Plan - Newser
Why Theravance Biopharma Inc. stock attracts strong analyst attentionEntry Level Low Risk Picks - Newser
Theravance Biopharma Inc. Stock Analysis and ForecastOutstanding capital appreciation - PrintWeekIndia
Is Theravance Biopharma Inc. a good long term investmentFree Predictions - Autocar Professional
What analysts say about Theravance Biopharma Inc. stockUnbelievable profit margins - PrintWeekIndia
Theravance Biopharma to Participate in an Upcoming Investor Conference - Citizen Tribune
What drives Theravance Biopharma Inc. stock priceConsistent triple-digit returns - jammulinksnews.com
How Theravance Biopharma Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser
Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics - The Globe and Mail
Theravance Biopharma SVP Farnum sells $113,869 in stock By Investing.com - Investing.com Nigeria
Theravance Biopharma SVP Farnum sells $113,869 in stock - Investing.com
5 Small Drug Stocks to Buy Amid Trump's New Tariff Threats - The Globe and Mail
Theravance Biopharma Inc (TBPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.97%
0.22%
자본화:
|
볼륨(24시간):